Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cidara Thera (CDTX)

Cidara Thera (CDTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics...

CDTX : 0.8371 (+1.32%)
Cidara Therapeutics and Mundipharma Announce Positive Topline Results from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis

Trial met FDA and EMA-pre-specified primary endpoints versus daily standard of care Data to support global regulatory filings in mid-2022 Cidara to host...

CDTX : 0.8371 (+1.32%)
Implied Volatility Surging for Cidara Therapeutics (CDTX) Stock Options

Investors need to pay close attention to Cidara Therapeutics (CDTX) stock based on the movements in the options market lately.

CDTX : 0.8371 (+1.32%)
Cidara Therapeutics (CDTX) Reports Q3 Loss, Tops Revenue Estimates

Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of 0.00% and 95.74%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

CDTX : 0.8371 (+1.32%)
Cidara Therapeutics: Q3 Earnings Snapshot

SAN DIEGO (AP) _ Cidara Therapeutics Inc. (CDTX) on Wednesday reported a loss of $18.1 million in its third quarter.

CDTX : 0.8371 (+1.32%)
Cidara Provides Corporate Update and Reports Third Quarter 2021 Financial Results

SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics...

CDTX : 0.8371 (+1.32%)
Cidara Therapeutics Announces Closing of Concurrent Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock

SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics...

CDTX : 0.8371 (+1.32%)
3 Stocks Under $10 Wall Street Predicts Will Surge by 50%

While there are several concerns, factors such as an expectation of solid third-quarter earnings and the continuation of near-zero interest rate policy should support the stock market in the coming months....

ARCO : 5.88 (+5.00%)
AGRO : 7.55 (+1.07%)
CDTX : 0.8371 (+1.32%)
Cidara Therapeutics Announces Pricing of Concurrent Public Offerings of Common Stock and Preferred Stock

SAN DIEGO, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics...

CDTX : 0.8371 (+1.32%)
Cidara Therapeutics Announces Commencement of Concurrent Public Offerings of Common Stock and Preferred Stock

SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics...

CDTX : 0.8371 (+1.32%)

Barchart Exclusives

Collect An 181% Return (Annualized) in Just 1 Day With the SPDR S&P 500 ETF
Investors looking to take advantage of the current market volatility with the following trade. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar